Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 8;1(1):27-31.
doi: 10.1176/appi.prcp.20180004. eCollection 2019 Apr.

Shared Decision-Making Tool for Treatment of Perinatal Opioid Use Disorder

Constance Guille  1   2 , Hendree E Jones  3 , Alfred Abuhamad  4 , Kathleen T Brady  1   5
Affiliations

Shared Decision-Making Tool for Treatment of Perinatal Opioid Use Disorder

Constance Guille et al. Psychiatr Res Clin Pract. .

Abstract

Objective: This study examined the proportion of pregnant women with opioid use disorder (OUD) who made a decision to continue or taper pharmacotherapy for the treatment of OUD after using a shared decision-making aid and determined whether the aid reflected the principles of the International Patient Decision Aid Standards (IPDAS).

Methods: A shared decision-making aid was developed with the IPDAS instrument to assist pregnant women with OUD receiving care at an outpatient obstetrics clinic in their decision to continue or taper pharmacotherapy for the treatment of OUD. After using the aid, the women (N=22) completed an anonymous survey about the extent to which the aid adhered to IPDAS principles.

Results: Eighty-two percent (22 of 27) of eligible participants agreed to take part in the study. After the shared decision-making process, 95% (21 of 22) reported choosing to either continue (64%, 14 of 22) or taper (36%, 8 of 22) pharmacotherapy for the treatment of OUD. Participants agreed that they were provided with sufficient information (96%, 21 of 22), outcome probabilities (91%, 20 of 22), and decisional guidance (86%-95% [19 and 21 of 22, respectively]) to make an informed decision. Further, women reported that their choice reflected their values and preferences (77%-91% [17 and 20 of 22, respectively]).

Conclusions: This shared decision aid provides a tool for providers to use with pregnant women with OUD to ensure that patients make informed treatment decisions that reflect their individual preferences and values.

Keywords: Buprenorphine; Methadone; Opioid Taper; Opioid Use Disorder; Pregnancy; Shared Decision Making.

PubMed Disclaimer

References

    1. Edwards A, Elwyn G: Shared decision‐making in health care: achieving evidence‐based patient choice; in Shared Decision‐Making in Health Care. Edited by Edwards A, Elwyn G. Oxford, Oxford University Press, 2009.
    1. Barry MJ, Edgman‐Levitan S: Shared decision making—pinnacle of patient‐centered care. N Engl J Med 2012; 366:780–781 - PubMed
    1. Stacey D, Légaré F, Lewis K, et al.: Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2017; 4:CD001431 - PMC - PubMed
    1. Say R, Robson S, Thomson R: Helping pregnant women make better decisions: a systematic review of the benefits of patient decision aids in obstetrics. BMJ Open 2011; 1:e000261 - PMC - PubMed
    1. Bateman BT, Hernandez‐Diaz S, Rathmell JP, et al.: Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology 2014; 120:1216–1224 - PMC - PubMed